Literature DB >> 15883260

Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies.

Héctor Manuel Barragán-Campos1, Jean-Noël Vallée, Daouda Lô, Carlos Felipe Barrera-Ramírez, Marcelo Argote-Greene, Jorge Sánchez-Guerrero, Bruno Estañol, Rémy Guillevin, Jacques Chiras.   

Abstract

BACKGROUND: Mitochondrial cytopathies (MCs) are a heterogeneous group of clinical entities, some of which have classic phenotypes. Magnetic resonance imaging (MRI) has been reported to be helpful in the diagnosis of MC.
OBJECTIVE: To correlate the most common brain MRI findings reported in patients with MC with the clinical findings in patients in different MC subgroups.
DESIGN: Case series.
SETTING: Patients with MCs seen at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico. PATIENTS: Twenty-one patients with MC with the following phenotypes: chronic progressive external ophthalmoplegia (n = 7), Kearns-Sayre syndrome (n = 7), mitochondrial neurogastrointestinal encephalopathy (n = 6), and myoclonic epilepsy with ragged red fiber myopathy (n = 1).
RESULTS: Brain MRI abnormalities were found in 20 (95%) of 21 patients. The most frequent abnormalities were widespread white matter hyperintensity in 19 patients (90%), supratentorial cortical atrophy in 18 patients (86%), and cerebellar atrophy in 13 patients (62%). Widespread white matter hyperintensity (P<.001) and supratentorial cortical atrophy (P = .001) were each correlated significantly with MC. Subsequent subgroup analyses showed that the absence of basal ganglia hyperintensity was correlated with Kearns-Sayre syndrome (P < .001) and the presence of supratentorial cortical atrophy was correlated with mitochondrial neurogastrointestinal encephalopathy (P = .005).
CONCLUSIONS: The presence of widespread white matter hyperintensity and/or supratentorial cortical atrophy in brain MRI may help to establish the diagnosis of MC. The radiologist has a role to play in the workup of MC by confirming the diagnosis and possibly distinguishing different subgroups of MC.

Entities:  

Mesh:

Year:  2005        PMID: 15883260     DOI: 10.1001/archneur.62.5.737

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Mimicry between mitochondrial disorder and multiple sclerosis.

Authors:  Josef Finsterer; Romana Höftberger; Claudia Stöllberger; Boris Rolinski
Journal:  Metab Brain Dis       Date:  2012-02-05       Impact factor: 3.584

2.  Conventional MRI and MR spectroscopy in nonclassical mitochondrial disease: report of three patients with mitochondrial DNA deletion.

Authors:  Leonardo Vedolin; Carolina Fischinger Moura de Souza; Rogério Schwark Silveira; Bianca Cunha Lopes; Leticia Saldanha Laybauer; Maria Luiza Saraiva Pereira; Roberto Giugliani
Journal:  Childs Nerv Syst       Date:  2006-03-22       Impact factor: 1.475

Review 3.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

4.  Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain.

Authors:  José Guevara-Campos; Lucía González-Guevara; Carmen Puig-Alcaraz; Omar Cauli
Journal:  Metab Brain Dis       Date:  2013-07-10       Impact factor: 3.584

5.  Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy.

Authors:  Seung-Koo Lee; Jinna Kim; Heung Dong Kim; Joon Soo Lee; Young Mock Lee
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

6.  Aberrant synthesis of ATP synthase resulting from a novel deletion in mitochondrial DNA in an African patient with progressive external ophthalmoplegia.

Authors:  Francois H van der Westhuizen; Joél Smet; Oksana Levanets; Madelein Meissner-Roloff; Roan Louw; Rudy Van Coster; Izelle Smuts
Journal:  J Inherit Metab Dis       Date:  2010-01-16       Impact factor: 4.982

7.  The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Mauro Scarpelli; Giuseppe Kenneth Ricciardi; Alberto Beltramello; Isabella Zocca; Francesca Calabria; Anna Russignan; Francesca Zappini; Maria Sofia Cotelli; Alessandro Padovani; Giuliano Tomelleri; Massimiliano Filosto; Paola Tonin
Journal:  Neuroradiol J       Date:  2013-11-07

Review 8.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 9.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

Review 10.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.